Stockreport

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

Tenaya Therapeutics, Inc.  (TNYA) 
PDF Aims to Build on Positive 2025 Interim TN-201 Results in First Half of 2026 with Longer-Term Follow-Up Data for Cohorts 1 and 2 from MyPEAK™-1 Trial of Adults with MYBPC [Read more]